Cristina giogha
Cristina giogha
Postdoctoral Scientist, Hudson Institute of Medical Research
Verified email at hudson.org.au
Title
Cited by
Cited by
Year
A type III effector antagonizes death receptor signalling during bacterial gut infection
JS Pearson, C Giogha, SY Ong, CL Kennedy, M Kelly, KS Robinson, ...
Nature 501 (7466), 247-251, 2013
2192013
EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation
JS Pearson, C Giogha, S Mühlen, U Nachbur, CLL Pham, Y Zhang, ...
Nature microbiology 2 (4), 1-10, 2017
932017
EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation
JS Pearson, C Giogha, S Mühlen, U Nachbur, CLL Pham, Y Zhang, ...
Nature microbiology 2 (4), 1-10, 2017
932017
SseK3 is a Salmonella effector that binds TRIM32 and modulates the host’s NF-κB signalling activity
Z Yang, A Soderholm, TWF Lung, C Giogha, MM Hill, NF Brown, ...
PLoS One 10 (9), e0138529, 2015
502015
The Genetics of Enteropathogenic Escherichia coli Virulence
JS Pearson, C Giogha, T Wong Fok Lung, EL Hartland
Annual review of genetics 50, 493-513, 2016
462016
Inhibition of death receptor signaling by bacterial gut pathogens
C Giogha, TWF Lung, JS Pearson, EL Hartland
Cytokine & growth factor reviews 25 (2), 235-243, 2014
462014
The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD)
NE Scott, C Giogha, GL Pollock, CL Kennedy, AI Webb, NA Williamson, ...
Journal of Biological Chemistry 292 (42), 17337-17350, 2017
342017
Salmonella effectors SseK1 and SseK3 target death domain proteins in the TNF and TRAIL signaling pathways
JPM Newson, NE Scott, IYW Chung, TWF Lung, C Giogha, J Gan, ...
Molecular & Cellular Proteomics 18 (6), 1138-1156, 2019
252019
Distinct roles of the antiapoptotic effectors NleB and NleF from enteropathogenic Escherichia coli
GL Pollock, CVL Oates, C Giogha, TWF Lung, SY Ong, JS Pearson, ...
Infection and immunity 85 (4), 2017
232017
The type III effector NleD from enteropathogenic Escherichia coli differentiates between host substrates p38 and JNK
K Creuzburg, C Giogha, TWF Lung, NE Scott, S Mühlen, EL Hartland, ...
Infection and immunity 85 (2), 2017
172017
Mutagenesis and functional analysis of the bacterial arginine glycosyltransferase effector NleB1 from enteropathogenic Escherichia coli
TWF Lung, C Giogha, K Creuzburg, SY Ong, GL Pollock, Y Zhang, ...
Infection and immunity 84 (5), 1346-1360, 2016
162016
Substrate recognition by the zinc metalloprotease effector NleC from enteropathogenic Escherichia coli
C Giogha, T Wong Fok Lung, S Mühlen, JS Pearson, EL Hartland
Cellular microbiology 17 (12), 1766-1778, 2015
162015
Filter by
JW Scott
11
The Salmonella Effector SseK3 Targets Small Rab GTPases
J Gan, NE Scott, JPM Newson, RR Wibawa, T Wong Fok Lung, ...
Frontiers in cellular and infection microbiology 10, 419, 2020
62020
EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation. Nat Microbiol 2: 16258
JS Pearson, C Giogha, S Muhlen, U Nachbur, CL Pham, Y Zhang, ...
52016
Molecular mechanisms employed by enteric bacterial pathogens to antagonise host innate immunity
J Gan, C Giogha, EL Hartland
Current Opinion in Microbiology 59, 58-64, 2021
32021
Sugar fix keeps RIPK3 at bay
C Giogha, KE Lawlor
Immunity 50 (3), 539-541, 2019
12019
Measuring Effector-Mediated Modulation of Inflammatory Responses to Infection with Enteropathogenic and Shiga Toxin-Producing E. coli.
GL Pollock, C Giogha, EL Hartland
Methods in Molecular Biology (Clifton, NJ) 2291, 317-332, 2021
2021
Molecular investigation of enteropathogenic Escherichia coli virulence
C Giogha
2016
The system can't perform the operation now. Try again later.
Articles 1–19